Pharmaco-proteogenomic profiling of pediatric high-grade gliomas

By performing pharmaco-proteogenomic investigations use statement (3 sentences MAX) we aim to couple genomics, proteomics and drug screening in real-time to guide/develop treatment approaches for pediatric high-grade glioma patients. As more tumour samples are analysed, we will gain a greater picture of the biology of these tumours and what influences their growth and survival with the primary objective of providing individualised treatment options for pHGG patients and their families, enhancing their survival prospects.